Back to Directory Murray Drulak Email mdrulak@rdg.boehringer-ingelheim.com Institution Boehringer Ingelheim Pharmaceuticals, Inc. Request an Update Affiliated Studies P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded P1043/HPTN 040: Neonatal prophylaxis for prevention of IP HIV DAIDS Number 10048 Research Area Other Study Status Concluded
P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded
P1043/HPTN 040: Neonatal prophylaxis for prevention of IP HIV DAIDS Number 10048 Research Area Other Study Status Concluded
